GxP Group is a UK-based life sciences technology company focused on making regulatory compliance more predictive, efficient, and accessible. Its GxP AI Insights Platform is a cloud-based SaaS solution that brings together regulatory and enforcement information to help pharmaceutical, medical device, and biotech organisations identify risks and make informed decisions. The platform currently integrates data from the US Food and Drug Administration and the European Medicines Agency, with additional global regulators planned.

Features include continuous regulatory monitoring, a regularly updated database, predictive risk forecasting, and advanced search and filtering. By automating data gathering, monitoring, and reporting, GxP Group aims to reduce manual work and compliance costs, support faster regulatory submissions, and help teams address potential issues before they lead to delays, recalls, or safety concerns. Its intended users include quality assurance leads, regulatory affairs managers, independent consultants, and regulatory executives.

GxP Group also offers product demonstrations and tailored discussions to help organisations assess the platform against their operational needs and compliance challenges